A 6-year-old girl from rural Maharashtra presents with recurrent episodes of vomiting, lethargy, and behavioral changes over 2 months. Serum ammonia is 120 µmol/L. Plasma amino acid analysis shows elevated glutamine and alanine; citrulline is low. Urine orotic acid is normal. Genetic testing reveals argininosuccinate lyase (ASL) deficiency. She is currently on a standard diet with normal protein intake. What is the most appropriate next step in management?

Explanation

## Management of Argininosuccinate Lyase (ASL) Deficiency ### Clinical Context ASL deficiency is a late-onset urea cycle disorder (UCDO) presenting in childhood with hyperammonemia, elevated plasma glutamine/alanine, **low citrulline** (substrate accumulates as argininosuccinate), and **normal urinary orotic acid** (unlike OTC deficiency). The low citrulline is pathognomonic. ### Pathophysiology ```mermaid flowchart TD A[Argininosuccinate]:::outcome --> B{ASL enzyme present?}:::decision B -->|Yes| C[Arginine + Fumarate]:::outcome B -->|No| D[Accumulation of argininosuccinate]:::urgent D --> E[Excretion in urine as argininosuccinic acid]:::outcome D --> F[Hyperammonemia]:::urgent F --> G[Neurological symptoms]:::outcome C --> H[Normal urea cycle]:::outcome ``` ### Tiered Management Approach **Key Point:** ASL deficiency has a more indolent course than OTC deficiency. Initial management is **protein restriction + L-arginine**, with ammonia scavengers added only if ammonia remains elevated despite these measures. **High-Yield:** L-arginine is ESSENTIAL in ASL deficiency because: 1. It is a substrate for arginosuccinate synthetase (the enzyme upstream of the block) 2. Argininosuccinate accumulation is toxic 3. Arginine supplementation drives the reaction forward and reduces argininosuccinate levels 4. Arginine also promotes ammonia removal via the intact urea cycle ### Step-by-Step Management | Step | Intervention | Rationale | |------|--------------|----------| | **1st line** | Protein restriction (1.0–1.5 g/kg/day) + L-arginine (100–200 mg/kg/day) | Reduces nitrogen load; L-arginine is essential cofactor | | **2nd line** | Add sodium benzoate if ammonia >100 µmol/L after 1–2 weeks | Ammonia scavenging if dietary measures insufficient | | **3rd line** | Add sodium phenylbutyrate if still inadequate | Dual ammonia-scavenging pathway | | **Monitoring** | Serum ammonia, plasma amino acids (citrulline, argininosuccinate), urine argininosuccinic acid | Track response and adjust therapy | **Clinical Pearl:** Unlike OTC deficiency (which requires immediate dual benzoate + phenylbutyrate), ASL deficiency often responds well to protein restriction + L-arginine alone, allowing a more gradual escalation of therapy. ### Why Normal Urinary Orotic Acid Matters Orotic acid elevation occurs only in **OTC deficiency** (carbamoyl phosphate shunts to pyrimidine synthesis). Normal orotic acid in ASL deficiency helps distinguish the two disorders and guides therapy selection. [cite:Harrison 21e Ch 355; KD Tripathi 8e Ch 12]